Examination of IMPA1 and IMPA2 genes in manic-depressive patients: association between IMPA2 promoter polymorphisms and bipolar disorder.
about
The genetics of bipolar disorder: genome ‘hot regions,’ genes, new potential candidates and future directionsVariation and genetic control of protein abundance in humansMolecular actions and clinical pharmacogenetics of lithium therapyAltered functional protein networks in the prefrontal cortex and amygdala of victims of suicideDefective craniofacial development and brain function in a mouse model for depletion of intracellular inositol synthesis.Strain differences in the gating-disruptive effects of apomorphine: relationship to gene expression in nucleus accumbens signaling pathwaysMaternal cocaine administration in mice alters DNA methylation and gene expression in hippocampal neurons of neonatal and prepubertal offspring.Genetic control of lithium sensitivity and regulation of inositol biosynthetic genes.Assessment of the effect of age at onset on linkage to bipolar disorder: evidence on chromosomes 18p and 21qAssociation between polymorphisms in the metallophosphoesterase (MPPE1) gene and bipolar disorder.Molecular pharmacology in a simple model system: implicating MAP kinase and phosphoinositide signalling in bipolar disorder.A promoter haplotype of the inositol monophosphatase 2 gene (IMPA2) at 18p11.2 confers a possible risk for bipolar disorder by enhancing transcription.Genetic variants in the IMPA2 gene do not confer increased risk of febrile seizures in Caucasian patients.Coordinated Expression of Phosphoinositide Metabolic Genes during Development and Aging of Human Dorsolateral Prefrontal CortexAdvances in myeloma genetics and prospects for pharmacogenomic testing in multiple myeloma.Science and society: applications of behavioural genetics: outpacing the science?Molecular genetics of bipolar disorder and depression.Treatment of bipolar disorder: new perspectives.Translating neurotrophic and cellular plasticity: from pathophysiology to improved therapeutics for bipolar disorder.IP3 accumulation and/or inositol depletion: two downstream lithium's effects that may mediate its behavioral and cellular changes.A promoter polymorphism rs2075824 within IMPA2 gene affecting the transcription activity: possible relationship with schizophreniaResponse to treatment in bipolar disorder.Prolyl oligopeptidase, inositol phosphate signalling and lithium sensitivity.A role for the PKC signaling system in the pathophysiology and treatment of mood disorders: involvement of a functional imbalance?Bipolar disorders in the Arab world: a critical review.Interaction of calbindin D28k and inositol monophosphatase in human postmortem cortex: possible implications for bipolar disorder.Human myo-inositol monophosphatase 2 rescues the nematode thermotaxis mutant ttx-7 more efficiently than IMPA1: functional and evolutionary considerations of the two mammalian myo-inositol monophosphatase genes.A gene co-expression module implicating the mitochondrial electron transport chain is associated with long-term response to lithium treatment in bipolar affective disorderIn silico study on the substrate binding manner in human myo-inositol monophosphatase 2
P2860
Q22251105-F4BCCEDF-3EA0-4B56-B1B3-5A04D465E4D5Q28290680-F8E823D0-2779-49FA-A089-DDC585E684B9Q28307770-AB9955E5-3991-4261-818B-D878CA966FABQ28485508-58A8198A-EFBE-4960-9C6B-A0D00A759C76Q30414460-BCC7376F-599D-4BF8-9BDC-1026EF8180F0Q30485498-F882E74F-7957-4F21-91C6-0FF91DCBC2B7Q33326645-27B3A942-7963-4761-8600-B86476EE00FBQ33612296-57A647D2-17D5-4ED7-9A7C-F6B2739D9A7CQ34114496-15507AC8-954C-407E-9377-7AB99C77DA36Q34530457-8452766C-B561-425D-B2D7-D8ADABBC070CQ34548121-B12E408D-AB7D-435B-81C4-53F08BCC3ED6Q34605987-3107FFDA-23B6-4065-90FE-E8D786F5AC6AQ34612679-9F7C3AE8-578E-4F63-8FC6-B196BDBE6BF8Q35689659-37B9A983-A4F9-4269-B207-D01E41D35FE4Q36052837-ABA92733-214F-4059-9E86-9B231EDE2E8CQ36246344-BD6F2CBB-28AB-4F9C-8CF1-4DEB60B2949FQ36713347-DB5A63A8-27FB-4272-B720-9A029C2C186FQ37280843-E8B7E85C-5722-4706-8401-2ABC202AEC99Q37607009-B62EEACE-F5CF-4DED-B348-F9ACDB65971BQ37650454-EEDF5E38-ADFE-4908-A56F-17BF0D954699Q37693352-8E73C44B-E6E8-4BC2-A2B6-7D604403928BQ37810764-D415AE28-B6D8-4C8C-8DB0-63334FA95E8DQ37827530-53CA4B2C-DC5C-4046-9BD0-1440DD5B63E6Q37943726-5148EB1E-0E4C-4D53-8B51-F55C906B31DAQ38346051-18B0E320-760D-4D4B-AD24-DC60D6B1F326Q45227604-B63C9BA2-0D24-4218-A914-6D70ED8A7DB5Q45405500-8A379147-802A-4F64-B770-3137C5D59416Q57077038-A1F21E89-EDBA-4B12-A57D-C6CA3A4D44DDQ57239753-1C905329-D850-409E-BDC0-054AC90CD691
P2860
Examination of IMPA1 and IMPA2 genes in manic-depressive patients: association between IMPA2 promoter polymorphisms and bipolar disorder.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Examination of IMPA1 and IMPA2 ...... orphisms and bipolar disorder.
@ast
Examination of IMPA1 and IMPA2 ...... orphisms and bipolar disorder.
@en
Examination of IMPA1 and IMPA2 ...... orphisms and bipolar disorder.
@nl
type
label
Examination of IMPA1 and IMPA2 ...... orphisms and bipolar disorder.
@ast
Examination of IMPA1 and IMPA2 ...... orphisms and bipolar disorder.
@en
Examination of IMPA1 and IMPA2 ...... orphisms and bipolar disorder.
@nl
prefLabel
Examination of IMPA1 and IMPA2 ...... orphisms and bipolar disorder.
@ast
Examination of IMPA1 and IMPA2 ...... orphisms and bipolar disorder.
@en
Examination of IMPA1 and IMPA2 ...... orphisms and bipolar disorder.
@nl
P2093
P2860
P356
P1433
P1476
Examination of IMPA1 and IMPA2 ...... orphisms and bipolar disorder.
@en
P2093
D F Levinson
I Bannoura
J F Deleuze
P2860
P2888
P304
P356
10.1038/SJ.MP.4001460
P407
P577
2004-06-01T00:00:00Z